University Hospital Ghent

Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24 (2020) Smolen J, Behrens F, Liu-Leage S, Sapin C, De La Torre I, Meszaros G, Schett G, et al. Conference contribution Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks (2020) Schett G, Van Den Bosch F, Baraliakos X, Sandoval D, Geneus V, Bolce R, Liu-Leage S, et al. Conference contribution FLAMINGO SET FOR THE ENDOSCOPIC TREATMENT OF BURIED BUMPER SYNDROME: MULTICENTRE, RETROSPECTIVE, COHORT STUDY (2020) Costa D, Despott EJ, Woodward J, Kohout P, Rath T, Scovell L, Gee I, et al. Conference contribution Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia (2020) Ebrahimi-Fakhari D, Teinert J, Behne R, Wimmer M, D'Amore A, Eberhardt K, Brechmann B, et al. Journal article Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND) (2020) Vera G, Sorlin A, Delplancq G, Lecoquierre F, Brasseur-Daudruy M, Petit F, Smol T, et al. Journal article Evolution of airway inflammation in preschoolers with asthma-results of a two-year longitudinal study (2020) Xepapadaki P, Korovessi P, Bachert C, Finotto S, Jartti T, Lakoumentas J, Kowalski ML, et al. Conference contribution, Conference Contribution TARGET OUTCOMES IN PSA: SIMULTANEOUS ACHIEVEMENT OF ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24 (2020) Smolen JS, Behrens F, Leage SL, Sapin C, De La Torre I, Meszaros G, Schett G, et al. Conference contribution Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score (2020) Schaule J, Kroeze SG, Blanck O, Stera S, Kahl KH, Roeder F, Combs SE, et al. Journal article Predictors of progression in systemic sclerosis patients with interstitial lung disease (2020) Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler J, et al. Journal article, Review article A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast) (2020) Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, Gravis G, et al. Conference contribution